Yahoo
NSE - Delayed Quote INR

Procter & Gamble Health Limited (PGHL.NS)

5,699.50 +186.00 (+3.37%)
At close: October 30 at 3:29:56 PM GMT+5:30
Chart Range Bar
Loading chart for PGHL.NS
  • Previous Close 5,513.50
  • Open 5,501.50
  • Bid --
  • Ask --
  • Day's Range 5,442.50 - 5,731.00
  • 52 Week Range 4,707.00 - 6,975.00
  • Volume 13,619
  • Avg. Volume 13,611
  • Market Cap (intraday) 94.608B
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) 26.49
  • EPS (TTM) 215.19
  • Earnings Date (est.) --
  • Forward Dividend & Yield 155.00 (2.73%)
  • Ex-Dividend Date Aug 27, 2026
  • 1y Target Est 7,090.00

Procter & Gamble Health Limited manufactures and markets pharmaceutical and chemical products in India and internationally. It offers over-the-counter products, vitamins, minerals, and supplements under the Betamil, Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen brand names. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. The company operates as a subsidiary of Procter & Gamble Overseas India B.V.

www.pghealthindia.com

1,276

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

PGHL.NS
3.75%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

PGHL.NS
4.20%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

PGHL.NS
28.36%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

PGHL.NS
23.77%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY19
Revenue 2.25B
Earnings --
Profit Margin 0.00%

Q4

FY18

Q1

FY19

Q2

FY19

Q3

FY19

0
2B
4B
6B
0.0%
100.0%
200.0%
300.0%

Analyst Insights

View More

Analyst Price Targets

7,090.00
7,090.00 Average
5,699.50 Current
7,090.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    24.91%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    14.33B

  • Net Income Avi to Common (ttm)

    3.57B

  • Diluted EPS (ttm)

    215.19

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.85B

  • Total Debt/Equity (mrq)

    1.77%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: